Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 43 CNY -4.04%
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acrobiosystems Co Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
PP&E Net
ÂĄ417.1m
CAGR 3-Years
144%
CAGR 5-Years
97%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
PP&E Net
ÂĄ9.3B
CAGR 3-Years
54%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
PP&E Net
ÂĄ2.4B
CAGR 3-Years
41%
CAGR 5-Years
66%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
PP&E Net
ÂĄ2.9B
CAGR 3-Years
46%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
PP&E Net
ÂĄ1.7B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
PP&E Net
ÂĄ5.1B
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
24%
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
48.56 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's PP&E Net?
PP&E Net
417.1m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's PP&E Net amounts to 417.1m CNY.

What is Acrobiosystems Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
97%

Over the last year, the PP&E Net growth was 161%. The average annual PP&E Net growth rates for Acrobiosystems Co Ltd have been 144% over the past three years , 97% over the past five years .

Back to Top